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This article reports the development of a pharmaceutical product containing vegetable actives from 
a Brazilian medicinal plant. The possibility of forming a microemulsion using Pterodon emarginatus 
(“sucupira”) oil was evaluated and the anti-inflammatory potential of this microemulsion was also 
examined. A formulation was developed using P. emarginatus oil, a mixture of ethoxylated Castor 
Oil (Ultramone® R-540/propylene glycol 2:1) (surfactant/cosurfactant) and distilled water at a ratio of 
10:15:75, respectively. The microemulsion which was selected was then subjected to the preliminary 
stability test and analyzed in terms of average diameter of droplets, pH, zeta potential, and polydispersity 
index, on the 1st, 7th, 15th, and 30th days after preparation and stored at different temperatures (5 ± 2 °C, 
25 ± 2 °C, and 40 ± 2 °C). The anti-inflammatory in vivo activity of both oil and formulation were 
evaluated, using the experimental model of croton oil-induced ear edema. The preliminary stability test 
showed that the microemulsion stored at 5 and 25 °C retained its original features throughout the 30-
day period. The anti-inflammatory potential of both oil and formulation was shown to be statistically 
significant (p < 0.001), when compared to the control group, however, the microemulsion proved to be 
more effective (p < 0.05) than the oil when applied directly to the ear.
Uniterms: Pterodon emarginatus/pharmacognosy. Pterodon emarginatus/oil/anti-inflammatory activity. 
Medicinal plants. Microemulsion. Phytomedicine. Pharmaceutical technology.
Descrevemos o desenvolvimento de um produto farmacêutico contendo ativo vegetal baseado em 
uma planta medicinal brasileira. Foi avaliada a habilidade de formação de uma microemulsão à base 
do óleo de Pterodon emarginatus (sucupira) e seu potential anti-inflamatório. Uma formulação foi 
desenvolvida utilizando o óleo de P. emarginatus, mistura de óleo de mamona etoxilado (Ultramona® 
R-540)/propilenoglicol (2:1) (tensoativo/cotensoativo) e água destilada, na proporção de 10:15:75, 
respectivamente. A microemulsão selecionada foi submetida ao teste preliminar de estabilidade e foi 
analisada quanto ao diâmetro médio das gotículas, pH, potential zeta e índice de polidispersão, no 
1º, 7º, 15º e 30º dias após o preparo e foram estocadas em diferentes temperaturas (5±2 °C, 25±2 °C 
e 40±2 °C). Avaliaram-se a atividade anti-inflamatória in vivo do óleo de sucupira e da formulação, 
usando o modelo experimental do edema de orelha induzido pelo óleo de cróton. No teste preliminar de 
estabilidade observou-se que a formulação estocada a 5 °C e a 25 °C mantiveram suas características 
originais durante 30 dias. O potencial anti-inflamatório de ambos, óleo de sucupira e formulação foi 
estatisticamente significativo (p <0.001), quando comparado ao controle, porém a microemulsão foi 
mais eficiente (p <0.05) que o óleo aplicado diretamente nas orelhas dos animais.
Unitermos: Pterodon emarginatus/pharmacognosy. Pterodon emarginatus/óleo/atividade anti-
inflamatória. Plantas medicinais. Microemulsão. Fitoterápico. Tecnologia farmacêutica.
H. Pascoa, D. G. A. Diniz, I. F. Florentino, E. A. Costa, M. T. F. Bara118
INTRODUCTION
The technological development of research on 
pharmaceutical forms containing herbal materials 
has expanded over recent decades and contributed 
to innovation in the pharmaceutical sector (Bassani, 
González, Petrovick, 2005; Calixto, 2005; Rocha et al., 
2008; Araújo-Júnior et al., 2013; Beringhs et al., 2013; 
Couto et al., 2013; Klein et al., 2013; Quintão et al., 2013).
Emulsified systems are characterized by their 
capacity to deliver drugs, and depending on the size of 
the globule and the process used, they can be classified 
as macroemulsions, microemulsions or nanoemulsions 
(Jafari, He, Bhandari, 2007). Microemulsion systems are 
defined as dispersions of two immiscible liquid phases, 
usually oil and water, stabilized by the presence of 
surfactants and cosurfactants at the oil/water interfaces 
(Lawrence, Rees, 2000; Oliveira et al., 2004; Frange, 
Garcia, 2009). An average diameter of droplets in a 
microemulsion generally ranges from 10-100 nm (100-
1000Å) (Shakeel, Ramadan, 2010; Jadhav, Shetye, 
Kadam, 2010).
Microemulsion formulations can increase drug 
transdermal permeation, as has been demonstrated in 
numerous studies (Kreilgaard, Pedersen, Jaroszewski, 
2000; Sintov, Sharipo, 2004; Hua et al., 2004; Sintov, 
Botner, 2006; Sintov, Brandys-Sitton, 2006; Heuschkel, 
Goebel, Neubert, 2008; Azeem et al., 2009; Neubert, 
2011). Several hypotheses have been put forward for 
the mechanism of drug permeation enhancement. These 
include increased drug solubility, which fosters a high 
concentration gradient towards skin, small droplet size and 
low viscosity which facilitates permeation, increased drug 
thermodynamic activity in the microemulsion vehicle, 
and the disruption of the stratum corneum lipid order by 
microemulsion components (Kreilgaard, 2002; Zhao et 
al., 2006; Biruss, Kählig, Valenta, 2007; Gupta, Moulik, 
2008; Vicentini et al., 2008; Moniruzzaman, Kamiya, 
Goto, 2010; Shakeel, Ramadan, 2010).
Pterodon emarginatus Vog. Fabaceae, known as 
“sucupira” is a tree species native to the Brazilian savanna 
(Lorenzi, 2002), whose fruit has shown anti-inflammatory, 
antiproliferactive, and antinoceptive activities (Carvalho 
et al., 1999; Euzébio et al., 2009; Spindola et al., 2011; 
Oliveira et al., 2012), based mainly on its diterpene 
content (Spindola et al., 2011). Although this fruit, which 
contains large amounts of oil, has been extensively 
studied both chemically and pharmacologically, there is 
no microemulsion product on the pharmaceutical market. 
Consequently, the aim of this study was to develop 
a microemulsion formulation containing Pterodon 
emarginatus oil and evaluate it for its anti-inflammatory 
potential.
MATERIAL AND METHODS
Material
Sorbitan monooleate (Span®80) and PEG-54 
Castor Oil (Ultramone® R540) were donated by Oxiteno. 
Polysorbate 80 (Tween®80) and propylene glycol (DEG), 
Ethyl alcohol (VETEC) were purchased from Atual 
Chemical Reagents Co. Ltda. The Pterodon emarginatus 
Vog. Fabaceae oil was obtained through the cold pressing 
of fruits collected in the town of São Domingos (Goiás - 
Brazil) (S13°42’12.9’’ W46°20’35.7’’). The plants were 
identified by Dr. Jose Realino de Paula at the Universidade 
Federal de Goiás. A voucher specimen was deposited 
in the Herbarium of the Universidade Federal de Goiás 
(UFG), Brazil, and cataloged under number 41714.
Hydrophilic‑Lipophilic Balance (HLB) required by 
P. emarginatus oil
To determine the required HLB for P. emarginatus 
oil the surfactants polysorbate 80 (Tween80®) with a 
HLB = 15.0 and sorbitan monooleate (Span80®) with a 
HLB = 4.3 were used. Table I shows the composition by 
weight of the components. The emulsions were prepared 
using the classic emulsification method. After preparation, 
the samples were transferred to a graduated tube and left to 
stand at room temperature for 24 hours. The HLB required 
for the P. emarginatus oil corresponds to the value of the 
sample with the lowest creaming percentage (Pereira, 2008).
Surfactant and cosurfactant system
To obtain the P. emarginatus oil microemulsions 
certain surfactant and cosurfactant systems were evaluated 
to find stable formulations. According to the HLB of the oil 
the necessary surfactants were chosen. The compositions 
of the formulations tested are described in Table II. The 
formulations were evaluated for macroscopic parameters 
such as the presence of bluish reflection and translucency, 
and for microscopic parameters, such as Brownian motion 
of particles and coalescence (Pereira, 2008).
Pseudo‑ternary diagram
To find the existence range of microemulsions, 
pseudo-ternary phase diagrams were constructed using 
the water titration method (Chen et al., 2004). For each 
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TABLE I - Proportion of lipophilic (Tween 80®) and hydrophilic (Span 80®) surfactants used to obtain the required HLB for P. 
emarginatus oil
Test HLB Oil (g) Tween 80® (g) Span 80® (g) Water (g)
1 5 2 0.13 1.87 16
2 6 2 0.32 1.68 16
3 7 2 0.50 1.50 16
4 8 2 0.69 1.31 16
5 9 2 0.88 1.12 16
6 10 2 1.07 0.93 16
7 11 2 1.25 0.75 16
8 12 2 1.44 0.56 16
9 13 2 1.63 0.37 16
10 14 2 1.81 0.19 16
11 15 2 2.00 0.00 16
TABLE II - Determination of concentrations in percentages of the components of the formulations tested to determine the surfactant/
cosurfactant system
Formulation Oil Water
Surfactant Cosurfactant
Tween 80® Ultramone R 540® Ethyl alcohol Propylene glycol
1 6.5 57 12.5 - 24 -
2 5 80 10 - - 5
3 10 75 10 - 5 -
4 10 75 - 10 - 5
5 10 75 - 10 5 -
phase diagram a specific surfactant/cosurfactant weight 
ratio (Ultramone® R-540/propylene glycol 2:1) was 
used. The ratios of P. emarginatus oil to the mixture of 
surfactant/cosurfactant and water were varied every 10% 
covering the entire area of an equilateral triangle. After 
being equilibrated, the mixtures were assessed visually and 
classified as being either microemulsions, emulsions or gels.
Microemulsion preparation
Microemulsions were prepared by reverse-phase 
methods. The water phase and oil phase with surfactants 
were heated separately to a temperature of 75±5 °C. The 
aqueous phase was added into the oil phase under magnetic 
stirring at room temperature (25 °C).
Characterization and stability of microemulsions
To evaluate microemulsion stability, stress 
conditions including aging, temperature and centrifugation 
were applied. The formulations were also subjected 
to centrifugation at 3000 rpm for 15 minutes at room 
temperature and samples were withdrawn after a 
particular time interval and observed for phase separation. 
The formulations selected were kept at three different 
temperatures i.e. 4 °C, 25 °C, 40 °C and observed for phase 
separation, pH, zeta potential and average particle size on 
the 1st, 7th, 15th, and 30th days after preparation (ANVISA, 
2004; Moghimipour, Salimi, Leis, 2012).
pH
The pH of the formulation was carried out using a 
Tecnal TEC 3MP pH meter (Tecnal, Piracicaba, São Paulo, 
Brazil). Analyses were performed in triplicate inserting 
the electrode directly into the sample without dilution 
(ANVISA, 2010).
Zeta potential
Zeta potential was determined by measuring the 
electrophoretic mobility of dispersed particles in an 
H. Pascoa, D. G. A. Diniz, I. F. Florentino, E. A. Costa, M. T. F. Bara120
electric field (ZetaPlus, Brookhaven, New York, USA). 
The formulations were diluted in distilled water (1:15), 
homogenized until completely dispersed and then 
subjected to analysis, which was performed in triplicate 
(Silveira, 2009; Moghimipour, Salimi, Leis, 2012).
Dynamic light scattering (DLS)
The particle size of the microemulsions and the 
polydispersity index were determined by the laser light 
scattering technique (Malvern Zetasizer Nano S, Malvern, 
UK). The sample was diluted with distilled water (1:10) 
and placed in cuvettes of 1 cm³ volume at a temperature 
of 25 °C. The measurements were performed in triplicate 
(Kale, Allen Jr, 1989; Silveira, 2009; Moghimipour, 
Salimi, Leis, 2012).
In vivo experiments
Animals
The experiment was conducted with male Swiss 
mice weighing from 40 to 45 g. They were kept under 
controlled temperature and light conditions (light/dark 
cycles of 12 h) with food and water ad libitum. The anti-
inflammatory studies were carried out in accordance 
with current norms of the Brazilian College of Animal 
Experimentation (COBEA), and authorized by the 
Research Ethics Committee (number 104/08) at the 
Universidade Federal de Goias.
Croton Oil-induced Ear Edema
The ear edema was induced as in the procedure 
previously described by Tubaro et al. (1985) cited in 
Pinheiro et al. (2011) with modifications. Three groups 
with 10 mice each were used. Inflammation was induced 
by applying 25 mL of acetone solution containing the 
irritant croton oil 2.5% v/v to the inner surface of the 
right ear of each animal. The left ear was used as a control 
and received 25 mL of vehicle (acetone). Thirty minutes 
after applying the irritant, the mice were treated with 
25 mL of the microemulsion formulation without the oil 
(negative control), 25 mL of P. emarginatus oil in acetone 
(100 mg/mL), and 25 mL of the microemulsion containing 
the P. emarginatus oil.
Four hours after applying the phlogistic agent the 
animals were euthanized and 6 mm discs were taken from 
both ears of each animal. The difference in weight between 
the discs was taken as the measurement of the edema. The 
anti-inflammatory activity of oil and formulation was 
evaluated by the difference between the values obtained 
for the negative control and those of the other groups.
Statistical Analyses
The results were expressed as mean ± S.D. For the 
group comparisons, one-way layout analysis of variance 
was applied. The data were analyzed statistically using 
variance analysis following Tukey’s comparison test. P 
values less than 0.05 were considered as indicative of 
significance using GraphPad Prism 4 (GraphPad software, 
San Diego, CA, USA).
RESULTS AND DISCUSSION
Hydrophilic‑Lipophilic Balance (HLB) required by 
P. emarginatus oil
The HLB required for the P. emarginatus oil 
was between 14 and 15 since these values presented a 
higher percentage of creaming as shown in Table III. 
The required HLB values were evaluated for the first 
time. The HLB parameter is an important tool for the 
technological development of phytopharmaceuticals and 
can be successfully employed in the formulation of natural 
products such as those based on vegetable oils (Fernandes 
et al., 2013)
Surfactant and cosurfactant system
The formulation with Ultramone R-540®/Propylene 
glycol showed better results when the parameters were 
compared (Table IV). According to Mittal (1999), the 
possibility of forming microemulsions depends on 
the balance between the hydrophilic and lipophilic 
TABLE III - Creaming profile obtained with the Tween 80® and 
Span 80® surfactant assessment for the HLB of P. emarginatus 
oil
HLB % Creaming
5 -
6 3.45
7 6.90
8 13.79
9 6.90
10 13.79
11 65.52
12 51.72
13 75.86
14 79.31
15 82.76
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TABLE IV - Macroscopic and microscopic analysis of formulations tested to evaluate the surfactant system with increased stability
Formulation
Macroscopic and microscopic parameters
Bluish reflection Translucency Brownian motion Particle homogeneity Coalescence
1 - + + - +
2 + + + - +
3 - - + - +
4 + + + + -
5 + + + - +
TABLE V – Percentage concentration (w/w) of the components 
of the formulation for the preparation of a new phase diagram 
in the microemulsion region
Formulation Oil S/Co-S Water
37 5 20 75
38 5 25 70
39 5 30 65
40 10 15 75
41 10 25 65
42 15 20 65
43 15 10 75
44 15 15 70
45 5 15 80
46 20 15 65
47 5 10 85
48 10 10 80
49 20 10 70
50 25 10 65
FIGURE 1 - Pseudo-ternary system for water, oil, surfactant/
cosurfactant (S/Co-S).
properties of the surfactant, which is determined not 
only by its chemical structure, but also by other factors 
such as temperature, ionic strength and the presence of 
cosurfactant. Pereira (2008) used the same parameters but 
for olive oil, grape seed oil and a mixture of both and found 
that the systems showed optimal stability when using a 
pair of surfactants (Ultroil R300® and Span® 80) whose 
HLB was equal to 8. Kale, Allen Jr (1989), Yaghmur et al. 
(2002), Yotsawimonwat et al. (2006) and Moghimipour, 
Salimi, Leis (2012) used propylene glycol as co-surfactant 
in different formulations of microemulsions.
Phase diagram
Pseudoternary phase diagrams with various weight 
ratios of surfactant/cosurfactant, P. emarginatus oil 
and water were prepared. The region circled in Figure 
1 (shown as number 22) represents the microemulsion 
formation regions.
Formulation 22 (10% P. emarginatus oil, 20% S/
Co-S, and 70% water) demonstrated greater stability 
for phase separation, as well as presenting the typical 
characteristics of the microemulsion, such as a bluish 
reflection, translucence, and absence of coalescence when 
analyzed under an optical microscope. Formulations 11, 
12, 13, 16, 17, 18, 23, 24, 29, 30, and 31 formed unstable 
emulsions when phase separation was complied with 
after centrifugation. The other formulations did not form 
emulsions showing gelified aspect with the separation of 
phases. The experimental results are described in Figure 1.
Based on these results, a new diagram was 
constructed around the Formulation 22 region to assess 
system behavior in relation to minor variations in the 
proportions of the components of the system. The new 
proportions analyzed are expressed in Table V.
The phase diagram presented in Figure 2 shows 
seven formulations (37, 38, 39, 40, 41, 45 and 47) with 
the characteristics of a microemulsion. All formulations 
presented closely resembling characteristics, but 
Formulation 40, which had the greatest concentration of 
P. emarginatus oil and a lower amount of surfactants in its 
composition, was selected for further study of its stability.
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The results obtained with the construction of the 
phase diagram are inherent to the oil and to the surfactant/
cosurfactant system used. However, Zhang, Michniak-
Kohn (2011) using Labrasol® (Caprylocaproyl macrogol 
8 glycerides) and Cremophor EL®(Polyoxyl 35 Castor 
oil), also noted that the formulations which showed 
the characteristics of a microemulsion were those in 
which the proportion of oil was lower than the ratio of 
surfactant/cosurfactant. Some studies are not consistent 
with the optimal microemulsion concept of high water 
content, a balanced quantity of oil and small amount of 
surfactant. Such studies describe optimal microemulsion 
formulations with a relatively high mixture of surfactants. 
In all those cases, the microemulsion systems under 
investigation used short-chain alcohol, such as ethanol, 
as the co-surfactant (Yuan et al., 2006; Zhu et al., 2008). 
Some surfactant molecules are known to self-assemble 
in polar organic solvents, such as propylene glycol, 
glycerol, and formamide. These solvents, like water, 
form hydrogen bonds and have relatively high dielectric 
constants. Critical micelle concentrations are higher in 
polar nonaqueous solvents than in water. When these 
solvents are used as water substitutes, their resulting 
penetration into the surfactant interface leads to smaller 
or no liquid crystal phase regions. Alcohols and polyols 
destabilize the liquid crystalline phase and extend the 
isotropic region to higher surfactant concentrations 
(Yaghmur et al., 2002).
Characterization and stability
The microemulsion obtained retained its original 
features when stored at temperatures of 5 °C and 25 °C. 
The formulation maintained at 40 °C showed a significant 
increase in droplet size and zeta potential and a reduction 
in pH (Figures 3, 4, and 5). Such variations could be 
justified by the fact that the physical stability of emulsions 
is generally intrinsically linked to the temperature to which 
the product is exposed (Chorilli et al., 2009).
FIGURE 2 - Phase diagram in the surroundings of Formulation 
22. Formulations presented in bold have the characteristics of 
a microemulsion while the other formulations presented only 
certain features of an emulsion.
FIGURE 3 - Change in mean diameter of droplets of internal 
phase as a function of time. Data expressed as mean and standard 
deviation (n=3).
FIGURE 4 - Variation of zeta potential versus time. Data 
expressed as mean and standard deviation (n=3).
FIGURE 5 - Changes in pH as a function of time. Data expressed 
as mean and standard deviation (n=3).
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The decrease in pH led to an increase in zeta-
potential, which can be explained by the mechanism of 
load generation at the interface. The increase in negative 
charge density increases the concentration of hydroxyl ions 
in a solution that tends to favor an increase in protons and 
a basic pH. On the other hand, a decrease in zeta potential, 
in module, as well as a more acidic pH can be explained by 
the neutralization of the negative regions as a result of the 
adsorption of hydrogen ions (Gallardo et al., 2005; Arias 
et al., 2008). The polydispersity index showed that all the 
microemulsions had narrow size distribution (Figure 6).
Anti‑inflammatory Activity
The results obtained in the evaluation of the anti-
inflammatory activity of the microemulsion system 
(Figure 7) show that both the formulation and the oil were 
statistically significant when compared to the negative control 
(p<0.001). The efficacy of the treatment was also shown 
FIGURE 6 - Polydispersity index as a function of time. Data 
expressed as mean and standard deviation (n=3).
FIGURE 7 - Ear edema, in mg, induced by croton oil (2.5% v/v 
in acetone) in groups previously treated topically. *** p<0.001 
(ANOVA, Tukey test) for treated groups versus control group. 
# p<0.05 (ANOVA, Tukey test) between treated groups.
when the use of the microemulsion with oil was compared to 
the application of the oil itself directly to the skin (p<0.05).
After carrying out the experiment we set out to 
see if the anti-inflammatory potential of the oil was 
retained after producing the microemulsion. The results 
obtained for P. emarginatus oil are consistent with those 
studies which show the anti-inflammatory activity of 
compounds, such as α-humulene and β-caryophyllene 
and vouacapanes (Spindola et al., 2011). Pinheiro et al. 
(2011), while employing the same experimental model, 
obtained a 76.63% inhibition of edema using the essential 
oil Peperomia serpens, which is rich in both substances. 
Fernandes et al. (2007) also obtained positive results for 
different experimental models of inflammation using 
α-humulene and β-caryophyllene, administered orally, 
isolated from the essential oil of Cordia verbenacea.
The use of microemulsions as a carrier vehicle 
in the topical formulations of drugs has been shown to 
improve the permeability of such formulations (Dantas 
et al., 2010; Hathout, Woodman, Mansour, 2010; Jadhav, 
Shetye, Kadam, 2010; Rogerio Dora, Andrade, 2010; 
Tsai et al., 2010). Bolzinger et al. (2008) showed that 
microemulsions based on caffeine have better permeation 
than pharmaceutical forms, such as emulsion and 
gel. Problems such as low drug bioavaibility and low 
penetration of formulations used topically in the different 
skin segments have been cited (Kreilgaard, 2002).
This study presents the first description of 
developing a potential anti-inflammatory microemulsion 
using “sucupira” oil as a basis. Further studies should 
be undertaken to investigate the permeation of the 
formulation on in vitro models, evaluate its anti-
inflammatory mechanism of action, define pharmaceutical 
forms to serve as a microemulsion vehicle and perform 
pre-clinical and clinical trials, in the near future, in 
order to contribute to innovation in the phytomedicine 
market.
CONCLUSION
A potential anti-inflammatory phytomedicine using 
P. emarginatus oil as a basis for use in pharmaceutical 
forms of microemulsion was formulated and characterized. 
This microemulsion is comprised of P. emarginatus oil 
(10%), a mixture of Ultramone® R-540/ propyleneglycol 
in a 2:1 ratio (15%) and water (75%). The average droplet 
diameter of the internal phase was 56.8 ± 6.07 nm, pH 
was 5.74 ± 0.19, zeta potential was -11.3 ± 1.54 mV while 
the polydispersity index showed that the microemulsion 
had narrow size distribution. Finally, we showed the 
potential anti-inflammatory activity of “sucupira” oil 
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and its efficacy as a vehicle in the pharmaceutical form 
of microemulsion.
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